Haemonetics (HAE) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.73 --0%
Revenue Growth %: +5.5%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
MLKN, KBH, WOR, More
Revenue Growth %: +5.5%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
MLKN, KBH, WOR, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.36, $0.04 better than the analyst estimate of $0.32. Revenue for the quarter came in at $213.4 million versus the consensus estimate of $215.62 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Citi upgrades Fifth Third Bancorp to Buy with $62 price target
- CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
